These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34103216)

  • 41. GLYCEMIC OUTCOMES 3 YEARS AFTER IMPLEMENTATION OF A PERI-OPERATIVE GLYCEMIC CONTROL ALGORITHM IN AN ACADEMIC INSTITUTION.
    Arnold LM; Mahesri M; McDonnell ME; Alexanian SM
    Endocr Pract; 2017 Feb; 23(2):123-131. PubMed ID: 27819771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.
    Grey NJ; Perdrizet GA
    Endocr Pract; 2004; 10 Suppl 2():46-52. PubMed ID: 15251640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.
    Mita N; Kawahito S; Soga T; Takaishi K; Kitahata H; Matsuhisa M; Shimada M; Kinoshita H; Tsutsumi YM; Tanaka K
    J Artif Organs; 2017 Mar; 20(1):76-83. PubMed ID: 27557726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of an artificial pancreas on postoperative inflammation in patients with esophageal cancer.
    Miyauchi R; Miki Y; Kasashima H; Fukuoka T; Yoshii M; Tamura T; Shibutani M; Toyokawa T; Lee S; Maeda K
    BMC Surg; 2024 Mar; 24(1):77. PubMed ID: 38431548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progressive artificial endocrine pancreas: The era of novel perioperative blood glucose control for surgery.
    Tsukamoto Y; Okabayashi T; Hanazaki K
    Surg Today; 2011 Oct; 41(10):1344-51. PubMed ID: 21922355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Perioperative Systems Design to Improve Intraoperative Glucose Monitoring Is Associated with a Reduction in Surgical Site Infections in a Diabetic Patient Population.
    Ehrenfeld JM; Wanderer JP; Terekhov M; Rothman BS; Sandberg WS
    Anesthesiology; 2017 Mar; 126(3):431-440. PubMed ID: 28106608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients.
    Lecomte P; Van Vlem B; Coddens J; Cammu G; Nollet G; Nobels F; Vanermen H; Foubert L
    Crit Care; 2008; 12(6):R154. PubMed ID: 19055829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective study on the effect of tight glucose control in postoperative sepsis patients using an artificial pancreas.
    Takahashi G; Matsumoto N; Shozushima T; Onodera C; Kan S; Akitomi S; Hoshikawa K; Kikkawa T; Kojika M; Inoue Y; Suzuki K; Wakabayashi G; Endo S
    J Infect Chemother; 2011 Dec; 17(6):812-20. PubMed ID: 21681499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative Closed-loop Glycemic Control Using an Artificial Pancreas in Patients After Esophagectomy.
    Kitagawa H; Yatabe T; Namikawa T; Munekage M; Hanazaki K
    Anticancer Res; 2016 Aug; 36(8):4063-7. PubMed ID: 27466514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycemic control in cardiac surgery: implementing an evidence-based insulin infusion protocol.
    Hargraves JD
    Am J Crit Care; 2014 May; 23(3):250-8. PubMed ID: 24786814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status and issues of the artificial pancreas: abridged English translation of a special issue in Japanese.
    Namikawa T; Munekage M; Yatabe T; Kitagawa H; Hanazaki K
    J Artif Organs; 2018 Jun; 21(2):132-137. PubMed ID: 29356912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project.
    Furnary AP; Wu Y; Bookin SO
    Endocr Pract; 2004; 10 Suppl 2():21-33. PubMed ID: 15251637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.
    Zisser H; Dassau E; Lee JJ; Harvey RA; Bevier W; Doyle FJ
    J Diabetes Sci Technol; 2015 May; 9(3):564-72. PubMed ID: 25901023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of Postoperative Infection Risk in Cardiac Surgery Patients With Delayed Sternal Closure.
    Li M; Mazzeffi MA; Gammie JS; Banoub M; Pazhani Y; Herr D; Madathil R; Pousatis S; Bathula A
    J Cardiothorac Vasc Anesth; 2020 May; 34(5):1238-1243. PubMed ID: 32127277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The preventive effects of perioperative oral care on surgical site infections after pancreatic cancer surgery: a retrospective study.
    Nobuhara H; Matsugu Y; Tanaka J; Akita T; Ito K
    Support Care Cancer; 2022 Apr; 30(4):3337-3344. PubMed ID: 34988706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time course changes in insulin sensitivity during cardiac surgery: A retrospective study on intraoperative glycemic management using an artificial pancreas.
    Uzawa M; Koda K; Kimura H; Kimura R; Ito Y; Saito A; Motomura N; Kitamura T
    Perfusion; 2024 Apr; 39(3):593-602. PubMed ID: 36757374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.